OnCore Login

Return to Trial Database

GI06-101

Phase II Trial of Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas: Hoosier Oncology Group GI06-101

Status

Study Completed

Cancer Type(s)

Liver and Bile Duct

Study Contact

Publications

Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers
  • EG Chiorean, R Ramasubbaiah, M Yu, J Picus, JA Bufill, Y Tong, N Coleman, EL Johnston, C Currie, PJ Loehrer

Trial Locations

All sites in which the trial GI06-101 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278